Tilray Brands, Incannex Healthcare, Indivior, Canopy Growth, and Turning Point Brands are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly listed companies operating in the legal cannabis industry, including the cultivation, processing, distribution and research of marijuana and hemp-derived products. Investing in these securities offers exposure to the rapidly growing medical and recreational cannabis markets but typically comes with elevated volatility and regulatory uncertainty. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Tilray Brands (TLRY)

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Shares of TLRY stock traded down $0.03 on Monday, reaching $0.51. The company had a trading volume of 26,014,386 shares, compared to its average volume of 29,979,001. The stock has a market capitalization of $509.29 million, a PE ratio of -0.48 and a beta of 1.82. Tilray Brands has a one year low of $0.35 and a one year high of $2.15. The company has a quick ratio of 1.61, a current ratio of 2.62 and a debt-to-equity ratio of 0.12. The business’s 50-day moving average is $0.43 and its 200 day moving average is $0.73.

Read Our Latest Research Report on TLRY

Incannex Healthcare (IXHL)

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.